Functional profiling of 2,193 ASS1 missense variants: Insights into variant pathogenicity and epistatic interactions in citrullinemia type I
Open Access
- 17 June 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 22 (6) , e1012167
Abstract
Sequence variants in the urea cycle gene argininosuccinate synthase ( ASS1 ) cause Citrullinemia type 1 (CTLN1), a rare autosomal recessive disease. Mechanistically, reduction in argininosuccinate synthetase (ASS) enzyme activity impairs the urea cycle, leading to an accumulation of citrulline and neurotoxic ammonia. Disease severity varies according to the degree of enzyme impairment, ranging from severe neonatal forms (classic citrullinemia) to milder, late-onset forms that may manifest in childhood or adulthood. We established a high-throughput yeast functional assay of human ASS and individually measured the impact of 2,193 amino acid substitutions, representing 90% of all single nucleotide variant (SNV)-accessible substitutions. When benchmarked against existing clinical variant annotation, our assay distinguishes known benign variants from strong loss of function pathogenic variants, enabling identification of a functional score threshold below which variants show clinically relevant impairment of ASS activity. Using the ACMG OddsPath framework, our assay meets PS3_supporting criteria for pathogenicity classification and achieves full PS3-level strength when variants observed as homozygotes in other primates are used as benign proxies for calibration. These results provide direct functional evidence to inform reclassification of ASS1 missense variants. Under the current ACMG guidelines, inclusion of our data yielded definitive classifications (pathogenic or likely pathogenic) for all 25 ClinVar VUS falling in the functionally impaired range of our assay. Mapping functional scores onto the protein structure, we confirmed that residues involved in catalysis are highly sensitive to substitution. In addition, we identified residues from adjacent subunits of the ASS homotetramer that form compound active sites. Assaying these positions revealed a capacity for intragenic complementation consistent with a variant sequestration model: a form of positive epistasis in which deleterious variants from different subunits are sequestered into only a subset of active sites, restoring function in the remaining variant-free sites. The discovery of intragenic complementation in ASS reveals a novel mode of functional interaction with clinical implications for interpreting variant combinations in heterozygous individuals.Keywords
Funding Information
- National Institute of Child Health and Human Development (R01HD114863)
- National Urea Cycle Disorders Foundation
This publication has 42 references indexed in Scilit:
- Expanded Newborn Screening Using Genome Sequencing for Early Actionable ConditionsJAMA, 2025
- When rare meets common: Treatable genetic diseases are enriched in the general psychiatric populationAmerican Journal of Medical Genetics Part A, 2024
- Analysis of ASS1 gene in ten unrelated middle eastern families with citrullinemia type 1 identifies rare and novel variantsMolecular Genetics & Genomic Medicine, 2023
- Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelinesHuman Mutation, 2020
- Early prediction of phenotypic severity in Citrullinemia Type 1Annals of Clinical and Translational Neurology, 2019
- Mutations in the Human Argininosuccinate Synthetase (ASS1) Gene, Impact on Patients, Common Changes, and Structural ConsiderationsHuman Mutation, 2017
- Mutations and polymorphisms in the human argininosuccinate synthetase (ASS1) geneHuman Mutation, 2008
- The role of molecular testing and enzyme analysis in the management of hypomorphic citrullinemiaAmerican Journal of Medical Genetics Part A, 2008
- Investigation of citrullinemia type I variants by in vitro expression studiesHuman Mutation, 2008
- Identification of 16 novel mutations in the argininosuccinate synthetase gene and genotype-phenotype correlation in 38 classical citrullinemia patientsHuman Mutation, 2003